ARCT - Arcturus Therapeutics Holdings Inc
IEX Last Trade
21.14
0.210 0.993%
Share volume: 261,753
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$20.93
0.21
1.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-09 | 2023-03-29 | 2023-05-09 | 2023-08-07 | 2023-11-14 | 2024-03-14 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 337.014 M | 293.627 M | 450.387 M | 470.863 M | 430.646 M | 457.650 M | 429.402 M | 418.849 M | |
| Current Assets | 291.505 M | 246.680 M | 403.333 M | 424.555 M | 385.244 M | 393.268 M | 386.590 M | 375.788 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 5.767 M | 6.960 M | 8.686 M | 4.137 M | 3.974 M | 8.130 M | 7.521 M | 5.335 M | |
| Short Term Investments | 5.767 M | 6.960 M | 8.686 M | 4.137 M | 3.974 M | 8.130 M | 7.521 M | 5.335 M | |
| Total Receivables | 2.247 M | 2.044 M | 2.764 M | 92.483 M | 2.799 M | 38.220 M | 32.064 M | 27.057 M | |
| Current Cash | 283.491 M | 237.676 M | 391.883 M | 327.935 M | 323.471 M | 311.918 M | 292.005 M | 288.396 M | |
| Total Non-current Assets | 45.509 M | 46.947 M | 47.054 M | 46.308 M | 45.402 M | 64.382 M | 42.812 M | 43.061 M | |
| Property Plant Equipment | 8.951 M | 11.347 M | 12.415 M | 12.635 M | 12.722 M | 12.715 M | 12.427 M | 11.763 M | |
| Other Assets | 34.480 M | 33.519 M | 32.545 M | 31.557 M | 30.553 M | 29.534 M | 28.500 M | 29.413 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 337.014 M | 293.627 M | 450.387 M | 470.863 M | 430.646 M | 457.650 M | 429.402 M | 418.849 M | |
| Total liabilities | 166.297 M | 147.960 M | 180.075 M | 141.615 M | 145.471 M | 177.588 M | 150.889 M | 154.877 M | |
| Total current liabilities | 92.743 M | 75.849 M | 126.984 M | 90.130 M | 90.345 M | 87.683 M | 81.989 M | 115.430 M | |
| Accounts Payable | 5.762 M | 17.962 M | 7.449 M | 19.344 M | 13.619 M | 18.362 M | 5.279 M | 9.144 M | |
| Other liabilities | 5.590 M | 8.855 M | 22.875 M | 22.298 M | 27.015 M | 42.887 M | 42.993 M | 11.795 M | |
| Current long term debt | 27.018 M | 27.702 M | 60.655 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 67.964 M | 63.256 M | 30.216 M | 29.187 M | 28.111 M | 47.018 M | 25.907 M | 27.652 M | |
| Other liabilities | 5.590 M | 8.855 M | 22.875 M | 22.298 M | 27.015 M | 42.887 M | 42.993 M | 11.795 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 170.717 M | 145.667 M | 270.312 M | 329.248 M | 285.175 M | 280.062 M | 278.513 M | 263.972 M | |
| Common stock | 26.425 M | 26.467 M | 26.512 M | 26.555 M | 26.563 M | 26.574 M | 26.820 M | 26.879 M | |
| Retained earnings | -420.222 M | -455.488 M | -338.141 M | -287.387 M | -339.937 M | -356.159 M | -367.866 M | -394.683 M |